CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming ...

Exagen reported a record-breaking fourth-quarter revenue of $17.2 million, marking the highest quarter in the company’s history. This represents a nearly 40% increase over the third quarter of 2024, ...

Exagen Inc. (NASDAQ:XGN) Q3 2025 Earnings Call Transcript November 4, 2025 Exagen Inc. misses on earnings expectations. Reported EPS is $-0.19 EPS, expectations were $-0.13. Operator: " Ryan Douglas: ...

Delivered record total revenue of $17.2 million, representing a 38% increase compared to the third quarter of 2024, or a 26% increase before the impact of one-time adjustments recorded in 2024. Grew ...

CARLSBAD, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, ...

WEST PALM BEACH, Fla. (AP) — New tests of the U.S. nuclear weapons system ordered up by President Donald Trump will not include nuclear explosions, Energy Secretary Chris Wright said Sunday. It was ...

BUSAN, South Korea -- President Donald Trump appeared to suggest the U.S. will resume testing nuclear weapons for the first time in three decades, saying it would be on an "equal basis" with Russia ...